{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T12:05:52Z","timestamp":1795176352858,"version":"4.10.3"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,2]]},"abstract":"<jats:p>Drug-induced anaphylaxis is a fatal medical condition whose incidence has been increasing continuously. Due to differences between genetic backgrounds and health care systems, different populations may be prone to various causative drugs. Using the Health Insurance Service and Assessment Service database, we investigated culprit drugs for drug-induced anaphylaxis and common medication risk factors in the Korean general population. We collected medical prescription histories within 3 days prior to anaphylaxis between January 2011 and December 2019 from the HIRA database. Designed as a case-crossover study, the attributable visits (case visits) were matched to medical visits (control visits) with the drug sets for each visit. We collected a list of medication risk factors for anaphylaxis and calculated the risk ratio of each agent using the chi-square test and conditional logistic regression analysis. A total of 159,473 individuals were listed in the database with a diagnosis of anaphylaxis in the HIRA from 2011 to 2019. After evaluating the suitability of control visits for matching with a case visit, 8168 subjects and 767 drugs were analyzed. The chi-square analysis identified 31 drugs as potential risk factors for drug-induced anaphylaxis in Korea. After applying a conditional logistic regression analysis for each agent, 5 drugs were found to be the common medication risk factors for drug-induced anaphylaxis: cefaclor, iopromide, iohexol, iomeprol, and tolperisone. We found 5 medication risk factors that showed the highest risk of drug-induced anaphylaxis and their degree of risk using an objective methodology in the Korean general population.<\/jats:p>","DOI":"10.1097\/md.0000000000030224","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T16:19:29Z","timestamp":1662135569000},"page":"e30224","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Risk factors of anaphylaxis in Korea: Identifying drug-induced anaphylaxis culprits using big data"],"prefix":"10.1097","volume":"101","author":[{"given":"Kyung-Min","family":"Ahn","sequence":"first","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea"},{"name":"Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Keun","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Allergy and Critical Care Medicine, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Suk","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea"},{"name":"Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea"},{"name":"Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1081-1206(10)60401-2","article-title":"Epidemiologic and clinical features of anaphylaxis in Korea","volume":"100","author":"Yang","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S1081-1206(10)61086-1","article-title":"Epidemiology of anaphylaxis: findings of the American college of allergy, asthma and immunology epidemiology of anaphylaxis working group","volume":"97","author":"Lieberman","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-7022-3-9","article-title":"The epidemiology of anaphylaxis in Europe: protocol for a systematic review","volume":"3","author":"Panesar","year":"2013","journal-title":"Clin Transl Allergy"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e5750","DOI":"10.1097\/MD.0000000000005750","article-title":"True rise in anaphylaxis incidence: epidemiologic study based on a national health insurance database","volume":"96","author":"Yang","year":"2017","journal-title":"Medicine"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-018-0251-z","article-title":"A population-based epidemiological study of anaphylaxis using national big data in Korea: trends in age-specific prevalence and epinephrine use in 2010\u20132014","volume":"14","author":"Jeong","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3904\/kjim.2018.094","article-title":"Prevalence of anaphylaxis and prescription rates of epinephrine auto-injectors in urban and rural areas of Korea","volume":"34","author":"Cho","year":"2019","journal-title":"Korean J Intern Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaci.2007.07.040","article-title":"Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005","volume":"120","author":"Poulos","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2008.09.043","article-title":"The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester epidemiology project","volume":"122","author":"Decker","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4168\/aair.2015.7.1.22","article-title":"Predictors of the severity and serious outcomes of anaphylaxis in Korean adults: a multicenter retrospective case study","volume":"7","author":"Ye","year":"2015","journal-title":"Allergy Asthma Immunol Res"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12016-015-8503-x","article-title":"The epidemiology of anaphylaxis","volume":"54","author":"Joyce","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report \u2013 second national institute of allergy and infectious disease\/food allergy and anaphylaxis network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4168\/aair.2016.8.6.535","article-title":"A multicenter retrospective case study of anaphylaxis triggers by age in Korean children","volume":"8","author":"Lee","year":"2016","journal-title":"Allergy Asthma Immunol Res"},{"key":"R13-20250504","first-page":"298","article-title":"Anaphylaxis; 10 years\u2019 experience at a university hospital in Suwon","volume":"28","author":"Kim","year":"2008","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R14-20250504","first-page":"169","article-title":"Incidence and clinical characteristics of pediatric emergency department visits of children with severe food allergy","volume":"32","author":"Lee","year":"2012","journal-title":"Korean Allergy Asthma Clin Immunol"},{"key":"R15-20250504","first-page":"137","article-title":"Drug-induced anaphylactic shock at the emergency department","volume":"7","author":"Han","year":"2009","journal-title":"J Korean Soc Clin Toxicol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.anai.2012.01.012","article-title":"Surveillance of contrast-media-induced hypersensitivity reactions using signals from an electronic medical recording system","volume":"108","author":"Kim","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R17-20250504","first-page":"S226","article-title":"Anaphylaxis in Korean adults: a multicenter retrospective case study","volume":"32","author":"Ye","year":"2012","journal-title":"Korean J Asthma Allergy Clin Immunol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"100449","DOI":"10.1016\/j.waojou.2020.100449","article-title":"A multicenter anaphylaxis registry in Korea: clinical characteristics and acute treatment details from infants to older adults","volume":"13","author":"Jeong","year":"2020","journal-title":"World Allergy Organ"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"e0165933","DOI":"10.1371\/journal.pone.0165933","article-title":"Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using national health insurance database in Korea","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/S0104-42302013000100004","article-title":"Anaphylaxis: diagnosis","volume":"59","year":"2013","journal-title":"Rev Assoc Med Bras"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a115853","article-title":"The case-crossover design: a method for studying transient effects on the risk of acute events","volume":"133","author":"Maclure","year":"1991","journal-title":"Am J Epidemiol"},{"key":"R23-20250504","first-page":"1","article-title":"Theory and practice of case-crossover study design","volume":"30","author":"Ki","year":"2008","journal-title":"Epidemiol Health"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaip.2018.06.010","article-title":"Drug-induced anaphylaxis documented in electronic health records","volume":"7","author":"Dhopeshwarkar","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/all.12168","article-title":"Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the allergy vigilance network from 2002 to 2010","volume":"68","author":"Renaudin","year":"2013","journal-title":"Allergy"},{"key":"R26-20250504","first-page":"40","article-title":"Drug-induced anaphylaxis survey in portuguese allergy departments","volume":"24","author":"Faria","year":"2014","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"R28-20250504","first-page":"547","article-title":"Hypersensitivity to contrast media and dyes.","volume":"34","author":"Brockow","year":"2014","journal-title":"Immunol Allergy Clin"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiol.2019190485","article-title":"Hypersensitivity reactions to iodinated contrast media: a multicenter study of 196,081 patients","volume":"293","author":"Cha","year":"2019","journal-title":"Radiology"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4168\/aard.2016.4.6.442","article-title":"Prevalence and clinical features of hypersensitivity reaction to contrast media after prescreening skin test","volume":"4","author":"Park","year":"2016","journal-title":"Allergy Asthma Respir Dis"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"299","DOI":"10.12932\/AP0297.31.4.2013","article-title":"Adverse reactions to iodinated contrast media: prevalence, risk factors and outcome \u2013 the results of a 3-year period","volume":"31","author":"Pradubpongsa","year":"2013","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2214\/AJR.04.1790","article-title":"Deaths attributed to X-ray contrast media on US death certificates.","volume":"186","author":"Wysowski","year":"2006","journal-title":"Am J Roentgenol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1148\/radiol.2019190829","article-title":"Relationship between lower dose and injection speed of iodinated contrast material for CT and acute hypersensitivity reactions: an observational study","volume":"293","author":"Park","year":"2019","journal-title":"Radiology"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3348\/kjr.2012.13.5.536","article-title":"Trends of CT use in the adult emergency department in a tertiary academic hospital of Korea during 2001-2010","volume":"13","author":"Oh","year":"2012","journal-title":"Korean J Radiol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3348\/jksr.2020.0124","article-title":"National health insurance system of Korea: resource-based relative value scale and a new healthcare policy","volume":"81","author":"Choi","year":"2020","journal-title":"J Korean Soc Radiol"},{"key":"R36-20250504","first-page":"61","article-title":"Main contents and tasks of second revision of resource-based relative value scale in Korea","author":"Kim","year":"2017","journal-title":"Korean Medical Association Health Policy Forum"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jaip.2020.01.014","article-title":"Anaphylaxis in the radiology suite","volume":"8","author":"Hsu Blatman","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaci.2015.07.035","article-title":"Analysis of cross-reactivity among radiocontrast media in 97 hypersensitivity reactions","volume":"137","author":"Lerondeau","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jaip.2017.10.040","article-title":"Skin testing for suspected iodinated contrast media hypersensitivity","volume":"6","author":"Schrijvers","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R40-20250504","first-page":"192","article-title":"Clinical and immunologic evaluations of immediate hypersensitivity to cefaclor","volume":"31","author":"Nam","year":"2011","journal-title":"Korean Allergy Asthma Clin Immunol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3349\/ymj.2014.55.6.1473","article-title":"Immunologic evaluation of immediate hypersensitivity to cefaclor","volume":"55","author":"Yoo","year":"2014","journal-title":"Yonsei Med J"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1527-3458.2008.00044.x","article-title":"Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects","volume":"14","author":"Quasthoff","year":"2008","journal-title":"CNS Neurosci Ther"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4168\/aair.2019.11.2.231","article-title":"Eperisone-induced anaphylaxis: pharmacovigilance data and results of allergy testing","volume":"11","author":"Park","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4168\/aard.2017.5.4.228","article-title":"A case series of eperisone-induced immediate hypersensitivity","volume":"5","author":"Kang","year":"2017","journal-title":"Allergy Asthma Respir Dis"},{"key":"R45-20250504","first-page":"279","article-title":"Clinical characteristics of eperisone-induced immediate-type hypersensitivity","volume":"38","author":"Shin","year":"2020","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R46-20250504","first-page":"250","article-title":"Mydocalm causing anaphylaxis","volume":"71","author":"Kwa\u015bniewski","year":"2003","journal-title":"Pneumonol Alergol Pol"},{"key":"R47-20250504","first-page":"369","article-title":"Anaphylactic reactions to tolperisone (Mydocalm\u00ae)","volume":"133","author":"Ribi","year":"2003","journal-title":"Swiss Med Wkly"},{"key":"R48-20250504","first-page":"8583753","article-title":"Severe anaphylactic reaction to diclofenac during intravenous anesthesia for in vitro fertilization","volume":"2019","author":"Videnovic","year":"2019","journal-title":"Case Rep Emerg Med"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"815e1","DOI":"10.1016\/j.ajem.2013.12.049","article-title":"Anaphylaxis after intramuscular injection of diclofenac sodium","volume":"32","author":"Colak","year":"2014","journal-title":"Am J Emerg Med"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s40521-017-0137-1","article-title":"NSAIDs-induced anaphylaxis","volume":"4","author":"Aun","year":"2017","journal-title":"Curr Treat Options Allergy"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:35:35Z","timestamp":1746333335000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":50,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030224","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]}}}